Charles River Laboratories CRL Segment operating income — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's segment operating income — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's segment operating income — operating income (loss)?
- Charles River Laboratories (CRL) reported segment operating income — operating income (loss) of $200.49M in Q1 2026.
- How has Charles River Laboratories's segment operating income — operating income (loss) changed year-over-year?
- Charles River Laboratories's segment operating income — operating income (loss) increased by 55.5% year-over-year, from $128.94M to $200.49M.
- What does segment operating income — operating income (loss) mean?
- The profit or loss earned by a specific business segment from its core operations.
- How do you interpret segment operating income — operating income (loss)?
- An increase indicates improved operational efficiency or higher margins within that specific business unit, while a decrease suggests rising costs, pricing pressure, or declining demand for that segment's services.
- How does segment operating income — operating income (loss) compare across companies?
- Peers in the contract research organization (CRO) industry typically report segment-level operating income to demonstrate the profitability of their distinct service offerings, such as discovery, safety assessment, or manufacturing support.